Concepedia

Author

Patrick Brossard

Actelion (Switzerland)ORCID

Also Known As

P. Brossard, Patrick Brossard

20

Publications

437

Citations

12

H-Index

27

Concepts

All Affiliations

Actelion (Switzerland)Philip Morris International (Switzerland)Clinical Research Services
PB

About

Patrick Brossard is an author at Actelion (Switzerland) specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

164

2

Public Health

2

2

28

3

Allergy

1

1

64

4

Endocrinology

1

1

16

5

Neuroscience

1

1

20

Patrick Brossard

×

13

Publications

423

Citations

12

H-Index

YearCitations

Pharmacokinetics and pharmacodynamics of ponesimod, a selective <scp>S1P<sub>1</sub></scp> receptor modulator, in the first‐in‐human study

Patrick Brossard, Hartmut Derendorf, Jian Xu,

British Journal of Clinical Pharmacology

2013

108

Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P<sub>1</sub>receptor modulator: Favorable impact of dose up-titration

Patrick Brossard, Michael W. Scherz, Atef Halabi,

The Journal of Clinical Pharmacology

2014

64

Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers

Patrick Brossard, Rolf Weitkunat, Valerie Poux,

Regulatory Toxicology and Pharmacology

2017

61

Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects

Matthias Hoch, Daniele D’Ambrosio, Darren Wilbraham,

European Journal of Pharmaceutical Sciences

2014

28

Population pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator

Andreas Krause, Patrick Brossard, Daniele D’Ambrosio,

Journal of Pharmacokinetics and Pharmacodynamics

2014

24

Differential effects of ponesimod, a selective S1P<sub>1</sub>receptor modulator, on blood-circulating human T cell subpopulations

Daniele D’Ambrosio, Jörg Steinmann, Patrick Brossard,

Immunopharmacology and Immunotoxicology

2014

22

Three different up-titration regimens of ponesimod, an S1P<sub>1</sub>receptor modulator, in healthy subjects

Michael W. Scherz, Patrick Brossard, Daniele D’Ambrosio,

The Journal of Clinical Pharmacology

2015

20

Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis

Mathilde Marchand, Patrick Brossard, Henri Merdjan,

European Journal of Drug Metabolism and Pharmacokinetics

2017

20

Mass balance, pharmacokinetics and metabolism of the selective S1P<sub>1</sub>receptor modulator ponesimod in humans

Maribel Reyes, Matthias Hoch, Patrick Brossard,

Xenobiotica

2014

19

Effect of Ponesimod, a Selective S1P<sub>1</sub> Receptor Modulator, on the QT Interval in Healthy Individuals

Matthias Hoch, Börje Darpö, Patrick Brossard,

Basic & Clinical Pharmacology & Toxicology

2014

18

Page 1